Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.

MLA

Kouamé, Gérard-Menan, et al. “Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.” Clinical Infectious Diseases, vol. 66, no. 1, Jan. 2018, pp. 112–20. EBSCOhost, https://doi.org/10.1093/cid/cix747.

APA

Kouamé, G.-M., Boyd, A., Moh, R., Badje, A., Gabillard, D., Ouattara, E., Ntakpe, J.-B., Emième, A., Maylin, S., & Chekaraou, M. A. (2018). Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Clinical Infectious Diseases, 66(1), 112–120. https://doi.org/10.1093/cid/cix747

Chicago

Kouamé, Gérard-Menan, Anders Boyd, Raoul Moh, Anani Badje, Delphine Gabillard, Eric Ouattara, Jean-Baptiste Ntakpe, Arlette Emième, Sarah Maylin, and Mariama Abdou Chekaraou. 2018. “Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.” Clinical Infectious Diseases 66 (1): 112–20. doi:10.1093/cid/cix747.